Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives $10.38 Consensus Target Price from Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has earned an average recommendation of “Moderate Buy” from the eleven brokerages that are covering the company, MarketBeat reports. Six analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $10.3750.

Several brokerages have recently commented on AVAH. BMO Capital Markets lowered their price objective on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a research report on Friday, March 20th. Truist Financial lowered their price objective on Aveanna Healthcare from $10.00 to $9.00 and set a “hold” rating on the stock in a research report on Friday, March 20th. Weiss Ratings downgraded Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday. Finally, Barclays lowered their price objective on Aveanna Healthcare from $11.00 to $9.50 and set an “overweight” rating on the stock in a research report on Wednesday, March 25th.

Aveanna Healthcare Price Performance

Shares of Aveanna Healthcare stock opened at $6.45 on Friday. The stock’s 50-day simple moving average is $7.24 and its 200-day simple moving average is $8.34. Aveanna Healthcare has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a market capitalization of $1.40 billion, a price-to-earnings ratio of 6.32 and a beta of 2.08. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 6.62.

Insider Buying and Selling

In related news, CAO Deborah Stewart sold 11,181 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $80,615.01. Following the sale, the chief accounting officer directly owned 301,807 shares in the company, valued at approximately $2,176,028.47. The trade was a 3.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Patrick A. Cunningham sold 18,436 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $132,923.56. Following the completion of the sale, the insider owned 337,755 shares in the company, valued at $2,435,213.55. This represents a 5.18% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 738,957 shares of company stock valued at $5,458,175 in the last ninety days. Company insiders own 7.80% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds have recently made changes to their positions in AVAH. AustralianSuper Pty Ltd purchased a new stake in shares of Aveanna Healthcare in the third quarter worth about $15,743,000. Vanguard Group Inc. lifted its position in shares of Aveanna Healthcare by 38.0% in the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after buying an additional 1,535,351 shares in the last quarter. Millennium Management LLC lifted its position in shares of Aveanna Healthcare by 1,007.1% in the fourth quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after buying an additional 1,014,030 shares in the last quarter. Nuveen LLC lifted its position in shares of Aveanna Healthcare by 135.9% in the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after buying an additional 905,316 shares in the last quarter. Finally, Hillsdale Investment Management Inc. purchased a new stake in shares of Aveanna Healthcare in the third quarter worth about $7,922,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.